Risk/benefit profile of bevacizumab in metastatic colon cancer: A systematic review and meta-analysis
Titel:
Risk/benefit profile of bevacizumab in metastatic colon cancer: A systematic review and meta-analysis
Auteur:
Galfrascoli, Elena Piva, Sheila Cinquini, Michela Rossi, Antonio La Verde, Nicla Bramati, Annalisa Moretti, Anna Manazza, Andrea Damia, Giovanna Torri, Valter Muserra, Gaetana Farina, Gabriella Garassino, Marina Chiara